Patients often ask a smarter question than it first appears: do GLP-1 medications reduce inflammation, or do they mainly help with weight loss and blood sugar while inflammation improves as a side effect
doi: 10.1038/mp.2016.44 Summary Keywords depression, glucagon-like peptide-1 (GLP-1), neuroinflammation, neurogenesis, synaptic plasticity Citation Kim Y-K, Kim OY and Song J (2020) Alleviation of Depression by Glucagon-Like Peptide 1 Through the Regulation of Neuroinflammation, Neurotransmitters, Neurogenesis, and Synaptic Function
Probiotics and their potential applications in active edible films and coatings
But this convenience has also created a Wild West of providers, pricing models, and service levels
In: Pagon RA, Adam MP, Bird TD, Dolan CR, Fong CT, Stephens K, eds